Abstract
Simulation models of opioid use disorder (OUD) aim at evaluating the impact of different treatment strategies on population-level outcomes. Researching Effective Strategies to Prevent Opioid Death (RESPOND) is a dynamic population state-transition model that simulates Massachusetts (MA) OUD population synthesizing data from the MA Public Health Data Warehouse, published survey studies, and randomized trials. We implement an empirical calibration approach to fit RESPOND to multiple calibration targets, including yearly counts of fatal overdoses and detox admissions in 2013-2015, and 2015 OUD population counts in MA. We used capture-recapture analysis to estimate the OUD population and to quantify uncertainty around calibration targets.1 The empirical calibration approach involves Latin hypercube sampling for a parameter search of the multidimensional space, comprising demographics of “arrivals”, overdose rates, treatment transition rates, and substance use transition probabilities. The algorithm accepts proposed parameter values when the respective model outputs are “close” to the observed calibration targets based on uncertainty ranges of targets. Calibration provided an excellent fit to the model calibration targets. The flexibility of the algorithm also allowed us to identify certain “questionable” parts of the model structure and explore the underlying relationships between the model parameters in an efficient manner. The calibrated model also provided a good fit to validation targets: non-overdose related deaths, percentage of active OUDs, and all types of overdose counts (fatal and non-fatal). In addition, the resulting set of values for the calibrated parameters will inform the priors of a more comprehensive Bayesian calibration. The calibrated RESPOND model will be employed to improve shared decision-making for OUD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institute on Drug Abuse (5R01DA046527-03)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The RESPOND model has been deemed non-human subjects research by the Boston University/Boston Medical Center Institutional Review Board (H-38867)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Minor formatting
Data Availability
All data produced in the present study are available upon reasonable request to the authors
